Clinical Trial Update: Minimally Invasive Surgery and rhTNK-tPA for Intracerebral Hemorrhage Evacuation [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating minimally invasive surgery plus rhTNK-tPA for evacuation of intracerebral hemorrhage has completed, sponsored by Beijing Tiant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Hemorrhage
• Cerebrovascular Disorders
• Intracerebral Hemorrhage

Drugs mentioned

• rhTNK-tPA (tenecteplase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Intracranial Hemorrhages, Cerebrovascular Disorders | Phase 1 | Status: COMPLETED